TGS1_HUMAN - dbPTM
TGS1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TGS1_HUMAN
UniProt AC Q96RS0
Protein Name Trimethylguanosine synthase
Gene Name TGS1
Organism Homo sapiens (Human).
Sequence Length 853
Subcellular Localization Cytoplasm . Nucleus, Cajal body . Nucleus, nucleolus . A 90 kDa isoform is found in the nucleus while a 55 kDa isoform is found in the cytoplasm and colocalizes with the tubulin network.
Protein Description Catalyzes the 2 serial methylation steps for the conversion of the 7-monomethylguanosine (m(7)G) caps of snRNAs and snoRNAs to a 2,2,7-trimethylguanosine (m(2,2,7)G) cap structure. The enzyme is specific for guanine, and N7 methylation must precede N2 methylation. Hypermethylation of the m7G cap of U snRNAs leads to their concentration in nuclear foci, their colocalization with coilin and the formation of canonical Cajal bodies (CBs). Plays a role in transcriptional regulation..
Protein Sequence MCCEKWSRVAEMFLFIEEREDCKILCLCSRAFVEDRKLYNLGLKGYYIRDSGNNSGDQATEEEEGGYSCGTAESHDSKGIGLDESELDSEAELMRSMGLPLQFGRITAHKDFEVSMNTRNKVKIKKKKHQKKYLDEIVQESWRKEYEEDDILASDDPSSIEQYENTRTYELQSKKDTETENPPVENTLSPKLEITEKWEKYWNEYGGGLLWQSWQEKHPGQALSSEPWNFPDTKEEWEQHYSQLYWYYLEQFQYWEAQGWTFDASQSCDTDTYTSKTEADDKNDEKCMKVDLVSFPSSPIMVDNDSSGTSDKDHSEILDGISNIKLNSEEVTQSQLDSCTSHDGHQQLSEVSSKRECPASGQSEPRNGGTNEESNSSGNTNTDPPAEDSQKSSGANTSKDRPHASGTDGDESEEDPPEHKPSKLKRSHELDIDENPASDFDDSGSLLGFKYGSGQKYGGIPNFSHRQVRYLEKNVKLKSKYLDMRRQIKMKNKHIFFTKESEKPFFKKSKILSKVEKFLTWVNKPMDEEASQESSSHDNVHDASTSSDSEEQDMSVKKGDDLLETNNPEPEKCQSVSSAGELETENYERDSLLATVPDEQDCVTQEVPDSRQAETEAEVKKKKNKKKNKKVNGLPPEIAAVPELAKYWAQRYRLFSRFDDGIKLDREGWFSVTPEKIAEHIAGRVSQSFKCDVVVDAFCGVGGNTIQFALTGMRVIAIDIDPVKIALARNNAEVYGIADKIEFICGDFLLLASFLKADVVFLSPPWGGPDYATAETFDIRTMMSPDGFEIFRLSKKITNNIVYFLPRNADIDQVASLAGPGGQVEIEQNFLNNKLKTITAYFGDLIRRPASET
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Ubiquitination---MCCEKWSRVAEM
---CCHHHHHHHHHH
36.23-
17UbiquitinationAEMFLFIEEREDCKI
HHHHHHHHCCCCCEE
43.6029967540
37UbiquitinationRAFVEDRKLYNLGLK
CHHHCCCCHHCCCCC
68.59-
39PhosphorylationFVEDRKLYNLGLKGY
HHCCCCHHCCCCCCE
16.0427642862
39UbiquitinationFVEDRKLYNLGLKGY
HHCCCCHHCCCCCCE
16.0429967540
44UbiquitinationKLYNLGLKGYYIRDS
CHHCCCCCCEEECCC
42.9723000965
51PhosphorylationKGYYIRDSGNNSGDQ
CCEEECCCCCCCCCC
33.3023927012
51UbiquitinationKGYYIRDSGNNSGDQ
CCEEECCCCCCCCCC
33.3029967540
55PhosphorylationIRDSGNNSGDQATEE
ECCCCCCCCCCCCCC
47.9826503892
60PhosphorylationNNSGDQATEEEEGGY
CCCCCCCCCCCCCCC
37.9926503892
61PhosphorylationNSGDQATEEEEGGYS
CCCCCCCCCCCCCCC
67.4432142685
67PhosphorylationTEEEEGGYSCGTAES
CCCCCCCCCCCCCCC
16.1928450419
68PhosphorylationEEEEGGYSCGTAESH
CCCCCCCCCCCCCCC
14.8923927012
71PhosphorylationEGGYSCGTAESHDSK
CCCCCCCCCCCCCCC
31.4230576142
74PhosphorylationYSCGTAESHDSKGIG
CCCCCCCCCCCCCCC
30.0823927012
77PhosphorylationGTAESHDSKGIGLDE
CCCCCCCCCCCCCCH
27.6223927012
81UbiquitinationSHDSKGIGLDESELD
CCCCCCCCCCHHHCH
35.4327667366
82UbiquitinationHDSKGIGLDESELDS
CCCCCCCCCHHHCHH
6.6229967540
85PhosphorylationKGIGLDESELDSEAE
CCCCCCHHHCHHHHH
43.0329255136
89PhosphorylationLDESELDSEAELMRS
CCHHHCHHHHHHHHH
51.8619664994
96PhosphorylationSEAELMRSMGLPLQF
HHHHHHHHCCCCEEC
11.8423917254
98UbiquitinationAELMRSMGLPLQFGR
HHHHHHCCCCEECCE
25.9529967540
104UbiquitinationMGLPLQFGRITAHKD
CCCCEECCEEEECCC
13.7129967540
110UbiquitinationFGRITAHKDFEVSMN
CCEEEECCCEEECCC
62.7429967540
115PhosphorylationAHKDFEVSMNTRNKV
ECCCEEECCCCCCCE
10.1028555341
121UbiquitinationVSMNTRNKVKIKKKK
ECCCCCCCEEECCHH
41.43-
132UbiquitinationKKKKHQKKYLDEIVQ
CCHHHHHHHHHHHHH
44.4629967540
141PhosphorylationLDEIVQESWRKEYEE
HHHHHHHHHHHHHCC
18.3228450419
144UbiquitinationIVQESWRKEYEEDDI
HHHHHHHHHHCCCCC
59.3929967540
146PhosphorylationQESWRKEYEEDDILA
HHHHHHHHCCCCCCC
27.8828176443
154PhosphorylationEEDDILASDDPSSIE
CCCCCCCCCCHHHHH
38.8225159151
158PhosphorylationILASDDPSSIEQYEN
CCCCCCHHHHHHHHH
51.4428176443
159PhosphorylationLASDDPSSIEQYENT
CCCCCHHHHHHHHHC
35.2223403867
163PhosphorylationDPSSIEQYENTRTYE
CHHHHHHHHHCCEEE
9.8028796482
166PhosphorylationSIEQYENTRTYELQS
HHHHHHHCCEEEEEC
16.6728796482
168PhosphorylationEQYENTRTYELQSKK
HHHHHCCEEEEECCC
21.2226552605
169PhosphorylationQYENTRTYELQSKKD
HHHHCCEEEEECCCC
16.0228796482
174UbiquitinationRTYELQSKKDTETEN
CEEEEECCCCCCCCC
41.5327667366
175UbiquitinationTYELQSKKDTETENP
EEEEECCCCCCCCCC
75.1229967540
177PhosphorylationELQSKKDTETENPPV
EEECCCCCCCCCCCC
54.4022817900
179PhosphorylationQSKKDTETENPPVEN
ECCCCCCCCCCCCCC
43.06-
187PhosphorylationENPPVENTLSPKLEI
CCCCCCCCCCCCEEE
18.3329978859
189PhosphorylationPPVENTLSPKLEITE
CCCCCCCCCCEEEHH
20.2525159151
191UbiquitinationVENTLSPKLEITEKW
CCCCCCCCEEEHHHH
56.2129967540
197UbiquitinationPKLEITEKWEKYWNE
CCEEEHHHHHHHHHH
52.5929967540
201PhosphorylationITEKWEKYWNEYGGG
EHHHHHHHHHHHCCC
11.27-
294PhosphorylationCMKVDLVSFPSSPIM
CEEEEEEECCCCCEE
38.4422115753
297PhosphorylationVDLVSFPSSPIMVDN
EEEEECCCCCEEECC
46.8925159151
298PhosphorylationDLVSFPSSPIMVDND
EEEECCCCCEEECCC
20.7725159151
306PhosphorylationPIMVDNDSSGTSDKD
CEEECCCCCCCCCCC
36.6022199227
307PhosphorylationIMVDNDSSGTSDKDH
EEECCCCCCCCCCCH
49.2922199227
309PhosphorylationVDNDSSGTSDKDHSE
ECCCCCCCCCCCHHH
35.3822199227
310PhosphorylationDNDSSGTSDKDHSEI
CCCCCCCCCCCHHHH
46.3022199227
315PhosphorylationGTSDKDHSEILDGIS
CCCCCCHHHHHHHHH
36.1425159151
322PhosphorylationSEILDGISNIKLNSE
HHHHHHHHCCCCCCH
37.7224144214
354AcetylationQLSEVSSKRECPASG
HHHHHHCCCCCCCCC
44.7226051181
357UbiquitinationEVSSKRECPASGQSE
HHHCCCCCCCCCCCC
3.8629967540
360PhosphorylationSKRECPASGQSEPRN
CCCCCCCCCCCCCCC
23.6230576142
363PhosphorylationECPASGQSEPRNGGT
CCCCCCCCCCCCCCC
53.7626552605
363UbiquitinationECPASGQSEPRNGGT
CCCCCCCCCCCCCCC
53.7629967540
377PhosphorylationTNEESNSSGNTNTDP
CCCCCCCCCCCCCCC
40.0730576142
380UbiquitinationESNSSGNTNTDPPAE
CCCCCCCCCCCCCHH
42.9229967540
389PhosphorylationTDPPAEDSQKSSGAN
CCCCHHHHHHCCCCC
30.8930576142
400UbiquitinationSGANTSKDRPHASGT
CCCCCCCCCCCCCCC
69.9429967540
405PhosphorylationSKDRPHASGTDGDES
CCCCCCCCCCCCCCC
38.9126503892
406UbiquitinationKDRPHASGTDGDESE
CCCCCCCCCCCCCCC
28.7129967540
407PhosphorylationDRPHASGTDGDESEE
CCCCCCCCCCCCCCC
34.0226503892
412PhosphorylationSGTDGDESEEDPPEH
CCCCCCCCCCCCCCC
51.5326503892
421UbiquitinationEDPPEHKPSKLKRSH
CCCCCCCCCCCCCCC
38.3129967540
422PhosphorylationDPPEHKPSKLKRSHE
CCCCCCCCCCCCCCC
56.2628176443
427PhosphorylationKPSKLKRSHELDIDE
CCCCCCCCCCCCCCC
21.5230576142
438PhosphorylationDIDENPASDFDDSGS
CCCCCCCCCCCCCCC
39.8130266825
443PhosphorylationPASDFDDSGSLLGFK
CCCCCCCCCCCCEEE
31.9330266825
445PhosphorylationSDFDDSGSLLGFKYG
CCCCCCCCCCEEEEC
25.1130266825
450UbiquitinationSGSLLGFKYGSGQKY
CCCCCEEEECCCCCC
47.0729967540
456UbiquitinationFKYGSGQKYGGIPNF
EEECCCCCCCCCCCC
49.7629967540
457PhosphorylationKYGSGQKYGGIPNFS
EECCCCCCCCCCCCC
16.8222817900
465UbiquitinationGGIPNFSHRQVRYLE
CCCCCCCHHHHHHHH
21.7629967540
473UbiquitinationRQVRYLEKNVKLKSK
HHHHHHHHHHCCCHH
65.5329967540
480UbiquitinationKNVKLKSKYLDMRRQ
HHHCCCHHHHHHHHH
48.52-
481PhosphorylationNVKLKSKYLDMRRQI
HHCCCHHHHHHHHHH
18.28-
493UbiquitinationRQIKMKNKHIFFTKE
HHHHHCCCEEEEECC
32.3429967540
499UbiquitinationNKHIFFTKESEKPFF
CCEEEEECCCCCCCC
54.8329967540
514SumoylationKKSKILSKVEKFLTW
CHHHHHHHHHHHHHH
51.47-
514AcetylationKKSKILSKVEKFLTW
CHHHHHHHHHHHHHH
51.4725953088
514SumoylationKKSKILSKVEKFLTW
CHHHHHHHHHHHHHH
51.47-
514UbiquitinationKKSKILSKVEKFLTW
CHHHHHHHHHHHHHH
51.4729967540
547PhosphorylationVHDASTSSDSEEQDM
CCCCCCCCCHHHHHC
45.2925954137
553UbiquitinationSSDSEEQDMSVKKGD
CCCHHHHHCCCCCCC
34.3021890473
555PhosphorylationDSEEQDMSVKKGDDL
CHHHHHCCCCCCCCH
38.7924719451
558UbiquitinationEQDMSVKKGDDLLET
HHHCCCCCCCCHHHC
66.4729967540
565PhosphorylationKGDDLLETNNPEPEK
CCCCHHHCCCCCCHH
40.0226552605
570UbiquitinationLETNNPEPEKCQSVS
HHCCCCCCHHHCCCC
47.8333845483
575PhosphorylationPEPEKCQSVSSAGEL
CCCHHHCCCCCCCEE
33.1830108239
577PhosphorylationPEKCQSVSSAGELET
CHHHCCCCCCCEECC
21.5130108239
578PhosphorylationEKCQSVSSAGELETE
HHHCCCCCCCEECCC
37.8323401153
583UbiquitinationVSSAGELETENYERD
CCCCCEECCCCCCCC
50.1829967540
584PhosphorylationSSAGELETENYERDS
CCCCEECCCCCCCCC
42.0026552605
587PhosphorylationGELETENYERDSLLA
CEECCCCCCCCCCEE
13.2026552605
615PhosphorylationPDSRQAETEAEVKKK
CCHHHHHHHHHHHHH
43.44-
646UbiquitinationAAVPELAKYWAQRYR
HHHHHHHHHHHHHHH
54.6821890473
663UbiquitinationSRFDDGIKLDREGWF
HCCCCCCCCCCCCCC
50.2721906983
676UbiquitinationWFSVTPEKIAEHIAG
CCCCCHHHHHHHHCH
48.7129967540
724UbiquitinationAIDIDPVKIALARNN
EEECCHHHHHHHHCC
27.87-
753PhosphorylationGDFLLLASFLKADVV
HHHHHHHHHHCCCEE
30.9518691976
781PhosphorylationAETFDIRTMMSPDGF
CEEEEEEEECCCCCH
19.9825072903
784PhosphorylationFDIRTMMSPDGFEIF
EEEEEECCCCCHHHE
14.7125072903
834UbiquitinationEQNFLNNKLKTITAY
EHHHHHCCHHHHHHH
50.7329967540
836UbiquitinationNFLNNKLKTITAYFG
HHHHCCHHHHHHHHH
39.22-
839PhosphorylationNNKLKTITAYFGDLI
HCCHHHHHHHHHHHH
22.1225262027
841PhosphorylationKLKTITAYFGDLIRR
CHHHHHHHHHHHHHC
10.2325262027

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
298SPhosphorylationKinaseMAPK1P28482
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TGS1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TGS1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
EED_HUMANEEDphysical
12943661
CBP_HUMANCREBBPphysical
11912212
EP300_HUMANEP300physical
11912212
NCOA6_HUMANNCOA6physical
11912212
MED1_HUMANMED1physical
11912212
NCOA6_HUMANNCOA6physical
11517327
NCOA6_HUMANNCOA6physical
12754253
EP300_HUMANEP300physical
12754253
SEPT7_HUMANSEPT7physical
26496610
CRY1_HUMANCRY1physical
26496610
ERCC5_HUMANERCC5physical
26496610
MYBPH_HUMANMYBPHphysical
26496610
SEPT2_HUMANSEPT2physical
26496610
SRBS1_HUMANSORBS1physical
26496610
MAGD2_HUMANMAGED2physical
26496610
AFG32_HUMANAFG3L2physical
26496610
DNJB4_HUMANDNAJB4physical
26496610
ZZEF1_HUMANZZEF1physical
26496610
SCRIB_HUMANSCRIBphysical
26496610
RSRC1_HUMANRSRC1physical
26496610
ZMYM1_HUMANZMYM1physical
26496610
LSM10_HUMANLSM10physical
26496610
ADIP_HUMANSSX2IPphysical
26496610
LSM11_HUMANLSM11physical
26496610
SEP10_HUMANSEPT10physical
26496610
TGS1_HUMANTGS1physical
26074133

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TGS1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55; THR-60; SER-89;SER-154 AND SER-438, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85; SER-89; SER-154;SER-298; SER-405; THR-407 AND SER-412, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55; THR-60; SER-85;SER-89; SER-154 AND SER-438, AND MASS SPECTROMETRY.

TOP